Comprehensive multi omics profiling and Mendelian randomization assessment of lipid metabolites in lung cancer prognosis

This study successfully developed robust machine learning-based prognostic models for LUSC with clinical utility for risk stratification and provided evidence that lipid alterations in lung cancer are likely downstream consequences rather than causal drivers of tumorigenesis.